期刊信息查詢系統

期刊標題檢索 ALLERGY ASTHMA 最新評論: The editor is quite capable. Recently, the impact factor has increased... (2022-04-18)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Allergy Asthma & Immunology Research]您好，您是該頁面的第 18538 位訪客。

期刊簡介

期刊名稱

Allergy Asthma & Immunology Research
LetPub Score

7.3

51 ratings

Rate

Reputation

8.2

Influence

6.2

Speed

9.7

期刊簡稱

ALLERGY ASTHMA IMMUN

ISSN

2092-7355

E-ISSN

2092-7363

h-index

CiteScore

SJR

SNIP

CiteScore Rank

6.10

0.801

0.763

Subject field	Quartiles	Rank	Percentile
Category: Medicine Subcategory: Pulmonary and Respiratory Medicine	Q2	42 / 155
Category: Medicine Subcategory: Immunology and Allergy	Q2	96 / 233
Category: Medicine Subcategory: Immunology	Q2	115 / 236

自引率 (2023-2024)

7.30%自引率趨勢

掲載範囲

The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.

官方網站

http://e-aair.org/

在線稿件提交

https://mc04.manuscriptcentral.com/aair

開放訪問

Yes

出版商

Korean Academy of Asthma, Allergy and Clinical Immunology

主題領域

ALLERGY

出版國/地區

SOUTH KOREA

發行頻率

創刊年

2009

每年文章數

55每年文章數趨勢

黃金OA百分比

100.00%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q2

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
ALLERGY	SCIE	Q2	13/39
IMMUNOLOGY	SCIE	Q2	74/181

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2092-7355%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions

競爭力 *

來自作者的數據: Moderate

參考鏈接

相關期刊	【Allergy Asthma & Immunology Research】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
Science Immunology	H-index: 0 CiteScore: 32.90
Journal of Allergy and Clinical Immunology-In Practice	H-index: 40 CiteScore: 11.10
Cancer Immunology Research	H-index: 62 CiteScore: 15.60
npj Vaccines	H-index: 8 CiteScore: 11.90
OncoImmunology	H-index: 58 CiteScore: 12.80
OncoImmunology	H-index: 49 CiteScore: 12.80
ALLERGOLOGY INTERNATIONAL	H-index: 45 CiteScore: 12.60
HLA	H-index: 93 CiteScore: 3.00
Immunity & Ageing	H-index: 38 CiteScore: 10.20
Clinical and Translational Allergy	H-index: 28 CiteScore: 7.50

學科內最受檢索的期刊	頁面查看次數
Journal of Inflammation Research	74081
Cancer Immunology Research	57216
OncoImmunology	55383
OncoImmunology	50279
Science Immunology	39954
npj Vaccines	29302
Human Vaccines & Immunotherapeutics	24538
Human Vaccines & Immunotherapeutics	24520
Endocrine Metabolic & Immune Disorders-Drug Targets	20831
Journal of Allergy and Clinical Immunology-In Practice	18771

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Allergy Asthma & Immunology Research] 的評論	撰寫評論

作者: wzygbb 領域: 医学審稿時間: 2.0 month(s) 結果: 修改後接受撰寫評論	2022-04-18 20:20:14 評論於 The editor is quite capable. Recently, the impact factor has increased a bit, making it more difficult to get published due to the higher standards. However, the Korean magazine still wants to accept articles from other countries, so articles of similar quality can give it a try. The review speed is also acceptable. (5) 讚！ \| wzygbb
作者: CSY 領域: 医学審稿時間: 1.0 month(s) 結果: 修改後接受撰寫評論	2020-01-18 14:44:47 評論於 This journal is relatively new, and is the journal of the Korean Academy of Asthma, Allergy & Clinical Immunology. The impact factor has increased significantly in the past two years; the annual collection volume is about 60 articles, including 25 reviews. It is at the level of Q3. In recent years, many experts in allergy field have published articles in this journal; I hope it will get better and better. And it is quite easy to be accepted. The review speed is relatively fast, but the self-citation rate is slightly high of more than 17%. Nov. 17, submissions; Dec. 19, revisions submitted. Although the major revision was required, the problems are easy to be solved. Dec. 28 revisions submitted; Jan. 1, accepted. (2) 讚！ \| CSY

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Allergy Asthma & Immunology Research] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: wzygbb 領域: 医学審稿時間: 2.0 month(s) 結果: 修改後接受撰寫評論	2022-04-18 20:20:14 評論於 The editor is quite capable. Recently, the impact factor has increased a bit, making it more difficult to get published due to the higher standards. However, the Korean magazine still wants to accept articles from other countries, so articles of similar quality can give it a try. The review speed is also acceptable. (5) 讚！ \| wzygbb
作者: CSY 領域: 医学審稿時間: 1.0 month(s) 結果: 修改後接受撰寫評論	2020-01-18 14:44:47 評論於 This journal is relatively new, and is the journal of the Korean Academy of Asthma, Allergy & Clinical Immunology. The impact factor has increased significantly in the past two years; the annual collection volume is about 60 articles, including 25 reviews. It is at the level of Q3. In recent years, many experts in allergy field have published articles in this journal; I hope it will get better and better. And it is quite easy to be accepted. The review speed is relatively fast, but the self-citation rate is slightly high of more than 17%. Nov. 17, submissions; Dec. 19, revisions submitted. Although the major revision was required, the problems are easy to be solved. Dec. 28 revisions submitted; Jan. 1, accepted. (2) 讚！ \| CSY

首頁上一頁 1 下一頁末頁 (頁 /1)

Allergy Asthma & Immunology Research

期刊標題檢索 ALLERGY ASTHMA 最新評論: The editor is quite capable. Recently, the impact factor has increased... (2022-04-18)

[Allergy Asthma & Immunology Research]您好，您是該頁面的第 18538 位訪客。

開始撰寫 [Allergy Asthma & Immunology Research] 的評論：

Contact us